Search results
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup
Market Watch· 2 hours agoHealth-care companies rose as optimism about a boom in obesity drugs regained momentum. Novo Nordisk shares ticked up after the maker of obesity injection...
The FTC is challenging 'junk' drug patents. Here's what they are and why they matter
Quartz· 1 day agoThe U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time,...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 6 hours agoStreet's projections. But sales of diabetes drugs Mounjaro and Trulicity missed forecasts. Lilly...
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 hours agoSangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the...
Huge News for SNDL Investors
Motley Fool via Yahoo Finance· 10 hours agoAs the Canadian market became oversupplied during the pandemic, the company nearly went bankrupt. However, Sundial miraculously became a meme stock...
Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
Barrons.com· 11 hours agoOn Thursday, the company unveiled a research project aimed at adding up to two more obesity...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 7 hours agoIt's important to note that the FDA placed an M4-focused drug from rival Neumora on hold on April...
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 hour agoIn addition, we will be referencing certain non-GAAP metrics in today's remarks. We have reconciled each non-GAAP metric to the nearest GAAP metric in...
Nut recall as "life-threatening" warning issued
Newsweek· 8 hours agoA nut recall was issued this week alongside warnings of a possible "life-threatening" allergic reaction. On Wednesday, the U.S. Food and Drug...
Teva, Medincell's schizophrenia drug succeeds in late-stage study
Reuters via Yahoo News· 2 days agoU.S.-listed shares of Teva were up 3.3% at $14.41 in premarket trading. The companies hope that the ...
